Purchase Short-Term Access

National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease
Otis W. Brawley, MD; Llewellyn J. Cornelius, PhD, LCSW; Linda R. Edwards, MD; Vanessa Northington Gamble, MD, PhD; Bettye L. Green, RN; Charles Inturrisi, PhD; Andra H. James, MD, MPH; Danielle Laraque, MD; Magda Mendez, MD; Carolyn J. Montoya, RN, MSN, CPNP; Brad H. Pollock, MPH, PhD; Lawrence Robinson, MD, MPH; Aaron P. Scholnik, MD; Melissa Schori, MD, MBA
Annals of Internal Medicine 2008;148:932-938. doi:10.7326/0003-4819-148-12-200806170-00220

Purchase Online access to this article for 24 hours
Buy Now

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.